{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:59:48Z","timestamp":1792162788040,"version":"4.4.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T00:00:00Z","timestamp":1652918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81600454"],"award-info":[{"award-number":["81600454"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671940"],"award-info":[{"award-number":["81671940"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871586"],"award-info":[{"award-number":["81871586"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770577"],"award-info":[{"award-number":["81770577"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012491","name":"Beijing Municipal Excellent Talents Foundation","doi-asserted-by":"publisher","award":["2018000021223ZK27"],"award-info":[{"award-number":["2018000021223ZK27"]}],"id":[{"id":"10.13039\/100012491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009331","name":"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support","doi-asserted-by":"publisher","award":["ZYLX201828"],"award-info":[{"award-number":["ZYLX201828"]}],"id":[{"id":"10.13039\/501100009331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00018-022-04319-w","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T14:03:29Z","timestamp":1652969009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Macrophages evoke autophagy of hepatic stellate cells to promote liver fibrosis in NAFLD mice via the PGE2\/EP4 pathway"],"prefix":"10.1007","volume":"79","author":[{"given":"Ying","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weili","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuwei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushi","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9078-2576","authenticated-orcid":false,"given":"Liuluan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,19]]},"reference":[{"key":"4319_CR1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","volume":"158","author":"M Eslam","year":"2020","unstructured":"Eslam M, Sanyal AJ, George J (2020) MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology 158:1999-2014e1991. https:\/\/doi.org\/10.1053\/j.gastro.2019.11.312","journal-title":"Gastroenterology"},{"key":"4319_CR2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/s0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi ZM, Gramlich T et al (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413\u20131419. https:\/\/doi.org\/10.1016\/s0016-5085(99)70506-8","journal-title":"Gastroenterology"},{"key":"4319_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R (2021) Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol 18:223\u2013238. https:\/\/doi.org\/10.1038\/s41575-020-00381-6","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4319_CR4","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J et al (2020) Nonalcoholic steatohepatitis: a review. JAMA 323:1175\u20131183. https:\/\/doi.org\/10.1001\/jama.2020.2298","journal-title":"JAMA"},{"key":"4319_CR5","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMra1300575","volume":"372","author":"DC Rockey","year":"2015","unstructured":"Rockey DC, Bell PD, Hill JA (2015) Fibrosis\u2014a common pathway to organ injury and failure. N Engl J Med 372:1138\u20131149. https:\/\/doi.org\/10.1056\/NEJMra1300575","journal-title":"N Engl J Med"},{"key":"4319_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y (2017) Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev 121:27\u201342. https:\/\/doi.org\/10.1016\/j.addr.2017.05.007","journal-title":"Adv Drug Deliv Rev"},{"key":"4319_CR7","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","volume":"157","author":"AA Widjaja","year":"2019","unstructured":"Widjaja AA, Singh BK, Adami E et al (2019) Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis. Gastroenterology 157:777-792e714. https:\/\/doi.org\/10.1053\/j.gastro.2019.05.002","journal-title":"Gastroenterology"},{"key":"4319_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-pathol-020117-043617","volume":"13","author":"JP Arab","year":"2018","unstructured":"Arab JP, Arrese M, Trauner M (2018) Recent insights into the pathogenesis of nonalcoholic fatty liver disease. Annu Rev Pathol 13:321\u2013350. https:\/\/doi.org\/10.1146\/annurev-pathol-020117-043617","journal-title":"Annu Rev Pathol"},{"key":"4319_CR9","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1111\/jcmm.13787","volume":"22","author":"X Cai","year":"2018","unstructured":"Cai X, Li Z, Zhang Q et al (2018) CXCL6-EGFR-induced Kupffer cells secrete TGF-beta1 promoting hepatic stellate cell activation via the SMAD2\/BRD4\/C-MYC\/EZH2 pathway in liver fibrosis. J Cell Mol Med 22:5050\u20135061. https:\/\/doi.org\/10.1111\/jcmm.13787","journal-title":"J Cell Mol Med"},{"key":"4319_CR10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/hep.26429","volume":"58","author":"JP Pradere","year":"2013","unstructured":"Pradere JP, Kluwe J, De Minicis S et al (2013) Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice. Hepatology 58:1461\u20131473. https:\/\/doi.org\/10.1002\/hep.26429","journal-title":"Hepatology"},{"key":"4319_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3389\/fimmu.2020.01169","volume":"11","author":"H Li","year":"2020","unstructured":"Li H, Zhou Y, Wang H et al (2020) Crosstalk between liver macrophages and surrounding cells in nonalcoholic steatohepatitis. Front Immunol 11:1169. https:\/\/doi.org\/10.3389\/fimmu.2020.01169","journal-title":"Front Immunol"},{"key":"4319_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","volume":"16","author":"K Kazankov","year":"2019","unstructured":"Kazankov K, Jorgensen SMD, Thomsen KL et al (2019) The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Nat Rev Gastroenterol Hepatol 16:145\u2013159. https:\/\/doi.org\/10.1038\/s41575-018-0082-x","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4319_CR13","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/hep4.1479","volume":"4","author":"G Parthasarathy","year":"2020","unstructured":"Parthasarathy G, Revelo X, Malhi H (2020) Pathogenesis of nonalcoholic steatohepatitis: an overview. Hepatol Commun 4:478\u2013492. https:\/\/doi.org\/10.1002\/hep4.1479","journal-title":"Hepatol Commun"},{"key":"4319_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18:151\u2013166. https:\/\/doi.org\/10.1038\/s41575-020-00372-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4319_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/hep.20798","volume":"42","author":"G Svegliati-Baroni","year":"2005","unstructured":"Svegliati-Baroni G, Inagaki Y, Rincon-Sanchez AR et al (2005) Early response of alpha2(I) collagen to acetaldehyde in human hepatic stellate cells is TGF-beta independent. Hepatology 42:343\u2013352. https:\/\/doi.org\/10.1002\/hep.20798","journal-title":"Hepatology"},{"key":"4319_CR16","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.4049\/jimmunol.1003260","volume":"187","author":"Y Liu","year":"2011","unstructured":"Liu Y, Meyer C, Muller A et al (2011) IL-13 induces connective tissue growth factor in rat hepatic stellate cells via TGF-beta-independent Smad signaling. J Immunol 187:2814\u20132823. https:\/\/doi.org\/10.4049\/jimmunol.1003260","journal-title":"J Immunol"},{"key":"4319_CR17","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jhep.2006.04.010","volume":"45","author":"P Czochra","year":"2006","unstructured":"Czochra P, Klopcic B, Meyer E et al (2006) Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice. J Hepatol 45:419\u2013428. https:\/\/doi.org\/10.1016\/j.jhep.2006.04.010","journal-title":"J Hepatol"},{"key":"4319_CR18","doi-asserted-by":"publisher","first-page":"2611","DOI":"10.1016\/j.ajpath.2014.06.009","volume":"184","author":"K Sakai","year":"2014","unstructured":"Sakai K, Jawaid S, Sasaki T et al (2014) Transforming growth factor-beta-independent role of connective tissue growth factor in the development of liver fibrosis. Am J Pathol 184:2611\u20132617. https:\/\/doi.org\/10.1016\/j.ajpath.2014.06.009","journal-title":"Am J Pathol"},{"key":"4319_CR19","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","volume":"142","author":"V Hernandez-Gea","year":"2012","unstructured":"Hernandez-Gea V, Ghiassi-Nejad Z, Rozenfeld R et al (2012) Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology 142:938\u2013946. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.044","journal-title":"Gastroenterology"},{"key":"4319_CR20","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.redox.2016.12.021","volume":"11","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Zhao S, Yao Z et al (2017) Autophagy regulates turnover of lipid droplets via ROS-dependent Rab25 activation in hepatic stellate cell. Redox Biol 11:322\u2013334. https:\/\/doi.org\/10.1016\/j.redox.2016.12.021","journal-title":"Redox Biol"},{"key":"4319_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida T, Friedman SL (2017) Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14:397\u2013411. https:\/\/doi.org\/10.1038\/nrgastro.2017.38","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4319_CR22","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jhep.2011.07.010","volume":"55","author":"LF Thoen","year":"2011","unstructured":"Thoen LF, Guimaraes EL, Dolle L et al (2011) A role for autophagy during hepatic stellate cell activation. J Hepatol 55:1353\u20131360. https:\/\/doi.org\/10.1016\/j.jhep.2011.07.010","journal-title":"J Hepatol"},{"key":"4319_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/path.5678","author":"F Lucantoni","year":"2021","unstructured":"Lucantoni F, Martinez-Cerezuela A, Gruevska A et al (2021) Understanding the implication of autophagy in the activation of hepatic stellate cells in liver fibrosis: are we there yet? J Pathol. https:\/\/doi.org\/10.1002\/path.5678","journal-title":"J Pathol"},{"key":"4319_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3978\/j.issn.2304-3881.2014.11.03","volume":"3","author":"R Weiskirchen","year":"2014","unstructured":"Weiskirchen R, Tacke F (2014) Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr 3:344\u2013363. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.11.03","journal-title":"Hepatobiliary Surg Nutr"},{"key":"4319_CR25","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.4049\/jimmunol.1201937","volume":"190","author":"RM Dunham","year":"2013","unstructured":"Dunham RM, Thapa M, Velazquez VM et al (2013) Hepatic stellate cells preferentially induce Foxp3+ regulatory T cells by production of retinoic acid. J Immunol 190:2009\u20132016. https:\/\/doi.org\/10.4049\/jimmunol.1201937","journal-title":"J Immunol"},{"key":"4319_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00418-006-0237-7","volume":"127","author":"T Ogawa","year":"2007","unstructured":"Ogawa T, Tateno C, Asahina K et al (2007) Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts. Histochem Cell Biol 127:161\u2013174. https:\/\/doi.org\/10.1007\/s00418-006-0237-7","journal-title":"Histochem Cell Biol"},{"key":"4319_CR27","doi-asserted-by":"publisher","first-page":"F52","DOI":"10.1152\/ajprenal.00260.2018","volume":"317","author":"E Ueshima","year":"2019","unstructured":"Ueshima E, Fujimori M, Kodama H et al (2019) Macrophage-secreted TGF-beta1 contributes to fibroblast activation and ureteral stricture after ablation injury. Am J Physiol Renal Physiol 317:F52\u2013F64. https:\/\/doi.org\/10.1152\/ajprenal.00260.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"4319_CR28","doi-asserted-by":"publisher","first-page":"4477","DOI":"10.1016\/j.biomaterials.2014.02.012","volume":"35","author":"KL Spiller","year":"2014","unstructured":"Spiller KL, Anfang RR, Spiller KJ et al (2014) The role of macrophage phenotype in vascularization of tissue engineering scaffolds. Biomaterials 35:4477\u20134488. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.02.012","journal-title":"Biomaterials"},{"key":"4319_CR29","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jhep.2014.11.011","volume":"62","author":"MF Sprinzl","year":"2015","unstructured":"Sprinzl MF, Puschnik A, Schlitter AM et al (2015) Sorafenib inhibits macrophage-induced growth of hepatoma cells by interference with insulin-like growth factor-1 secretion. J Hepatol 62:863\u2013870. https:\/\/doi.org\/10.1016\/j.jhep.2014.11.011","journal-title":"J Hepatol"},{"key":"4319_CR30","doi-asserted-by":"publisher","first-page":"205873842096609","DOI":"10.1177\/2058738420966092","volume":"34","author":"LW Hsu","year":"2020","unstructured":"Hsu LW, Huang KT, Nakano T et al (2020) MicroRNA-301a inhibition enhances the immunomodulatory functions of adipose-derived mesenchymal stem cells by induction of macrophage M2 polarization. Int J Immunopathol Pharmacol 34:2058738420966092. https:\/\/doi.org\/10.1177\/2058738420966092","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4319_CR31","doi-asserted-by":"publisher","first-page":"E3186","DOI":"10.1073\/pnas.1119964109","volume":"109","author":"P Ramachandran","year":"2012","unstructured":"Ramachandran P, Pellicoro A, Vernon MA et al (2012) Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis. Proc Natl Acad Sci USA 109:E3186-3195. https:\/\/doi.org\/10.1073\/pnas.1119964109","journal-title":"Proc Natl Acad Sci USA"},{"key":"4319_CR32","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1080\/15384047.2018.1564567","volume":"20","author":"XY Zeng","year":"2019","unstructured":"Zeng XY, Xie H, Yuan J et al (2019) M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. Cancer Biol Ther 20:956\u2013966. https:\/\/doi.org\/10.1080\/15384047.2018.1564567","journal-title":"Cancer Biol Ther"},{"key":"4319_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1053\/gast.2003.50012","volume":"124","author":"C Yang","year":"2003","unstructured":"Yang C, Zeisberg M, Mosterman B et al (2003) Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 124:147\u2013159. https:\/\/doi.org\/10.1053\/gast.2003.50012","journal-title":"Gastroenterology"},{"key":"4319_CR34","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/hep.27376","volume":"61","author":"LD DeLeve","year":"2015","unstructured":"DeLeve LD (2015) Liver sinusoidal endothelial cells in hepatic fibrosis. Hepatology 61:1740\u20131746. https:\/\/doi.org\/10.1002\/hep.27376","journal-title":"Hepatology"},{"key":"4319_CR35","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1165\/rcmb.2014-0343OC","volume":"53","author":"F Romero","year":"2015","unstructured":"Romero F, Shah D, Duong M et al (2015) A pneumocyte-macrophage paracrine lipid axis drives the lung toward fibrosis. Am J Respir Cell Mol Biol 53:74\u201386. https:\/\/doi.org\/10.1165\/rcmb.2014-0343OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"4319_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106854","volume":"88","author":"X Deng","year":"2020","unstructured":"Deng X, Yang Q, Wang Y et al (2020) CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C(+) M2-like macrophage infiltration. Int Immunopharmacol 88:106854. https:\/\/doi.org\/10.1016\/j.intimp.2020.106854","journal-title":"Int Immunopharmacol"},{"key":"4319_CR37","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1681\/ASN.2016050573","volume":"28","author":"YY Wang","year":"2017","unstructured":"Wang YY, Jiang H, Pan J et al (2017) Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury. J Am Soc Nephrol 28:2053\u20132067. https:\/\/doi.org\/10.1681\/ASN.2016050573","journal-title":"J Am Soc Nephrol"},{"key":"4319_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.cca.2020.03.024","volume":"506","author":"H Yang","year":"2020","unstructured":"Yang H, Xuefeng Y, Shandong W, Jianhua X (2020) COX-2 in liver fibrosis. Clin Chim Acta 506:196\u2013203. https:\/\/doi.org\/10.1016\/j.cca.2020.03.024","journal-title":"Clin Chim Acta"},{"key":"4319_CR39","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/hep.21108","volume":"43","author":"J Yu","year":"2006","unstructured":"Yu J, Ip E, Dela Pena A et al (2006) COX-2 induction in mice with experimental nutritional steatohepatitis: role as pro-inflammatory mediator. Hepatology 43:826\u2013836. https:\/\/doi.org\/10.1002\/hep.21108","journal-title":"Hepatology"},{"key":"4319_CR40","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11010-011-1016-x","volume":"359","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Wang Y, Wang Q et al (2012) Hepatic stellate cells produce vascular endothelial growth factor via phospho-p44\/42 mitogen-activated protein kinase\/cyclooxygenase-2 pathway. Mol Cell Biochem 359:217\u2013223. https:\/\/doi.org\/10.1007\/s11010-011-1016-x","journal-title":"Mol Cell Biochem"},{"key":"4319_CR41","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1096\/fj.04-2753fje","volume":"19","author":"A Planaguma","year":"2005","unstructured":"Planaguma A, Claria J, Miquel R et al (2005) The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARgamma activation. FASEB J 19:1120\u20131122. https:\/\/doi.org\/10.1096\/fj.04-2753fje","journal-title":"FASEB J"},{"key":"4319_CR42","doi-asserted-by":"publisher","first-page":"3420","DOI":"10.1172\/JCI127550","volume":"129","author":"K Nakamura","year":"2019","unstructured":"Nakamura K, Kageyama S, Ito T et al (2019) Antibiotic pretreatment alleviates liver transplant damage in mice and humans. J Clin Invest 129:3420\u20133434. https:\/\/doi.org\/10.1172\/JCI127550","journal-title":"J Clin Invest"},{"key":"4319_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.162","volume":"5","author":"A Gonzalez-Rodriguez","year":"2014","unstructured":"Gonzalez-Rodriguez A, Mayoral R, Agra N et al (2014) Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis 5:e1179. https:\/\/doi.org\/10.1038\/cddis.2014.162","journal-title":"Cell Death Dis"},{"key":"4319_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1164\/rccm.201501-0161OC","volume":"193","author":"R Domingo-Gonzalez","year":"2016","unstructured":"Domingo-Gonzalez R, Martinez-Colon GJ, Smith AJ et al (2016) Inhibition of neutrophil extracellular trap formation after stem cell transplant by prostaglandin E2. Am J Respir Crit Care Med 193:186\u2013197. https:\/\/doi.org\/10.1164\/rccm.201501-0161OC","journal-title":"Am J Respir Crit Care Med"},{"key":"4319_CR45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/mi.2017.51","volume":"11","author":"GJ Martinez-Colon","year":"2018","unstructured":"Martinez-Colon GJ, Taylor QM, Wilke CA et al (2018) Elevated prostaglandin E2 post-bone marrow transplant mediates interleukin-1beta-related lung injury. Mucosal Immunol 11:319\u2013332. https:\/\/doi.org\/10.1038\/mi.2017.51","journal-title":"Mucosal Immunol"},{"key":"4319_CR46","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1124\/pr.110.003517","volume":"63","author":"DF Woodward","year":"2011","unstructured":"Woodward DF, Jones RL, Narumiya S (2011) International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress. Pharmacol Rev 63:471\u2013538. https:\/\/doi.org\/10.1124\/pr.110.003517","journal-title":"Pharmacol Rev"},{"key":"4319_CR47","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jhep.2014.08.023","volume":"62","author":"XF Li","year":"2015","unstructured":"Li XF, Chen DP, Ouyang FZ et al (2015) Increased autophagy sustains the survival and pro-tumourigenic effects of neutrophils in human hepatocellular carcinoma. J Hepatol 62:131\u2013139. https:\/\/doi.org\/10.1016\/j.jhep.2014.08.023","journal-title":"J Hepatol"},{"key":"4319_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12943-019-0944-z","volume":"18","author":"GM Jiang","year":"2019","unstructured":"Jiang GM, Tan Y, Wang H et al (2019) The relationship between autophagy and the immune system and its applications for tumor immunotherapy. Mol Cancer 18:17. https:\/\/doi.org\/10.1186\/s12943-019-0944-z","journal-title":"Mol Cancer"},{"key":"4319_CR49","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.4161\/auto.7.10.16649","volume":"7","author":"H Ugland","year":"2011","unstructured":"Ugland H, Naderi S, Brech A et al (2011) cAMP induces autophagy via a novel pathway involving ERK, cyclin E and Beclin 1. Autophagy 7:1199\u20131211. https:\/\/doi.org\/10.4161\/auto.7.10.16649","journal-title":"Autophagy"},{"key":"4319_CR50","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1038\/onc.2012.252","volume":"32","author":"C Gong","year":"2013","unstructured":"Gong C, Bauvy C, Tonelli G et al (2013) Beclin 1 and autophagy are required for the tumorigenicity of breast cancer stem-like\/progenitor cells. Oncogene 32:2261\u20132272. https:\/\/doi.org\/10.1038\/onc.2012.252","journal-title":"Oncogene"},{"key":"4319_CR51","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1338239","volume":"6","author":"DI Albu","year":"2017","unstructured":"Albu DI, Wang Z, Huang KC et al (2017) EP4 Antagonism by E7046 diminishes myeloid immunosuppression and synergizes with Treg-reducing IL-2-Diphtheria toxin fusion protein in restoring anti-tumor immunity. Oncoimmunology 6:e1338239. https:\/\/doi.org\/10.1080\/2162402X.2017.1338239","journal-title":"Oncoimmunology"},{"key":"4319_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000222","author":"DS Hong","year":"2020","unstructured":"Hong DS, Parikh A, Shapiro GI et al (2020) First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2019-000222","journal-title":"J Immunother Cancer"},{"key":"4319_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1471-230X-14-131","volume":"14","author":"L Flores-Contreras","year":"2014","unstructured":"Flores-Contreras L, Sandoval-Rodriguez AS, Mena-Enriquez MG et al (2014) Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C. BMC Gastroenterol 14:131. https:\/\/doi.org\/10.1186\/1471-230X-14-131","journal-title":"BMC Gastroenterol"},{"key":"4319_CR54","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Ratziu V, Loomba R et al (2019) Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 394:2184\u20132196. https:\/\/doi.org\/10.1016\/S0140-6736(19)33041-7","journal-title":"Lancet"},{"key":"4319_CR55","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","volume":"385","author":"BA Neuschwander-Tetri","year":"2015","unstructured":"Neuschwander-Tetri BA, Loomba R, Sanyal AJ et al (2015) Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial. Lancet 385:956\u2013965. https:\/\/doi.org\/10.1016\/S0140-6736(14)61933-4","journal-title":"Lancet"},{"key":"4319_CR56","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt EM, Kleiner DE, Wilson LA et al (2011) Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53:810\u2013820. https:\/\/doi.org\/10.1002\/hep.24127","journal-title":"Hepatology"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04319-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04319-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04319-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T12:08:00Z","timestamp":1656158880000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04319-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,19]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["4319"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04319-w","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,19]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study on human patients was approved by the Ethics Committee of the Beijing Ditan Hospital, Capital Medical University (approval number: 2018-047-01). All the individuals involved in the study have signed the written informed consent. The study on animals was conducted according to the 1998 XXVIII Hungarian law about animal protection and welfare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors read and approved the final paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"303"}}